Peter Ho is an accomplished professional in the pharmaceutical and academic sectors, currently serving as Director on the Board of Directors and as a Scientific Advisory Board Member at Overland Pharmaceuticals, as well as in similar advisory roles at HiFiBiO Therapeutics, Tavotek Biotherapeutics, and Accent Therapeutics, Inc. Additionally, Peter holds the position of Adjunct Lecturer at The Johns Hopkins University and Adjunct Associate Professor at UNC Eshelman School of Pharmacy, while also advising the Cleveland Clinic and acting as a Senior Advisor at D3 Bio. With a strong educational background that includes an M.D. and Ph.D. from the Yale School of Medicine and a Bachelor of Arts in Biology from The Johns Hopkins University, Peter has demonstrated significant expertise in the fields of medicine and pharmacology.
This person is not in any teams
This person is not in any offices